Navigation Links
Long-term Marijuana Smoking Leads to Respiratory Complaints

Long-term exposure to marijuana smoke is linked to many of the same health problems as tobacco smoke, such as increased respiratory// symptoms like cough, phlegm and wheeze, according to a new study by researchers at Yale School of Medicine.

Marijuana is the most widely used illicit drug in the United States, and abuse of the drug is on the rise. The study is published in today’s Archives of Internal Medicine. First author Jeanette M. Tetrault, M.D., and colleagues sought to find the relationship between marijuana smoking and pulmonary function or respiratory complications.

“While there is convincing data on the effects of tobacco smoke on pulmonary clinical outcomes, the effect of marijuana smoke has been poorly understood,” said Tetrault, ambulatory care fellow at Yale School of Medicine and the Department of Veterans Affairs Connecticut Healthcare System.

Tetrault and colleagues systematically reviewed articles from 1966 through 2005 identified from the MEDLINE, PsychINFO and EMBASE databases that evaluated the effect of marijuana smoking on pulmonary function and respiratory complications. Of the 34 articles that met selection criteria, 12 were classified as challenge studies because they examined the link between short-term marijuana use and airway response. Eleven of the 12 studies found an association between short-term marijuana use and relaxation and opening of the air passages.

The study’s physiologic data failed to show an association between long-term marijuana smoking and airflow obstruction (emphysema). However, all 14 studies that assessed long-term marijuana smoking and respiratory complications noted an association with increased respiratory symptoms, suggesting obstructive lung disease.

The authors noted several common limitations among the studies, including inadequate control of the complicating effect of tobacco smoking; lack of standardized measures for the amount or duration of mar ijuana use; and lack of standardized measures of the outcomes that were evaluated.

“Despite these limitations, clinicians should advise their patients of the potential negative impact of marijuana smoking on overall lung health,” said Tetrault.

Source-YALE UniversitySRM

Related medicine news :

1. Long-term use of calcium supplements to prevent colon cancer
2. Long-term Care Should Be A Planned Affair
3. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
4. Global AIDS Conference Calls for Long-term Strategies
5. Long-term Use of Stomach Drugs may Weaken Bones
6. Asthma Sufferers Favor Quick Relief Over Long-term Control
7. Tamoxifen Yields Long-term Reduction in Breast Cancer Risk
8. Marijuana gateway theory strengthened by study of twins
9. Marijuana Use Could Result In Psychosis
10. Wife May Determine Husband’s Marijuana Use
11. E-Mail Affects Brain More Than Marijuana
Post Your Comments:

(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: